Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice
- 1 September 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 311 (1) , 7-14
- https://doi.org/10.1016/0014-2999(96)00390-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anxiogenic stimuli in the elevated plus-mazePublished by Elsevier ,2002
- The mammalian tachykinin receptorsGeneral Pharmacology: The Vascular System, 1995
- Peptide‐based tachykinin NK2 receptor antagonistsMedicinal Research Reviews, 1995
- Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious ratsNeuropharmacology, 1994
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- The Role of the Amygdala in Fear and AnxietyAnnual Review of Neuroscience, 1992
- Substance P in CSF of patients with chronic pain syndromesPain, 1988
- Intracerebroventricular injections in miceJournal of Pharmacological Methods, 1986
- Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature, 1980
- A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.Journal of the American Pharmaceutical Association (Scientific ed.), 1957